Please login to the form below

Not currently logged in
Email:
Password:

aHUS

This page shows the latest aHUS news and features for those working in and with pharma, biotech and healthcare.

Amgen takes aim at Alexion’s patents for Soliris

Amgen takes aim at Alexion’s patents for Soliris

and atypical haemolytic uremic syndrome (aHUS).

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • NICE and ‘ultra orphans’ NICE and ‘ultra orphans’

    There are currently around 140 people diagnosed with aHUS in England, but and at least another 140 people are estimated to have the condition but be undiagnosed. ... The drug had been assessed in aHUS by AGNSS, which was convinced of its clinical

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics